首页> International journal of biological macromolecules> Biohybrid hydrogel inhibiting β-klotho/HDAC3 axis for hepatocellular carcinoma treatment.

Biohybrid hydrogel inhibiting β-klotho/HDAC3 axis for hepatocellular carcinoma treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gaolin,Wen

第一单位： Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China.

作者： Gaolin,Wen ^[1] ; Lingling,Xue ^[1] ; Mengdi,Qiu ^[1] ; Junlan,Qiu ^[2] ; Xinhua,Zhu ^[3] ; Haozhen,Ren ^[4]

作者单位： Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China. ^[1] Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China. Electronic address: weiyumo@163.com. ^[2] Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China. Electronic address: drzhuxh@163.com. ^[3] Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing 210008, China; Division of Hepatobiliary and Transplantation Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, China. Electronic address: haozhenren@njglyy.com. ^[4]

关键词 Biohybrid Hepatocellular carcinoma Hydrogel β-Klotho